AIM ImmunoTech
AIM
$0.38
Share price
-2.84%
Change (1 day)
-28.32%
Change (1 year)
Categories
Operating Margin for AIM ImmunoTech (AIM)
Operating Margin as of June 2024 (TTM): -13,889.30%
According to AIM ImmunoTech 's latest financial reports and stock price the company's current Operating Margin is -13,889.30%. At the end of 2021 the company had an Operating Margin of -14,168.15%.
Operating Margin history for AIM ImmunoTech from 2001 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -14,168.15% | 60.38% |
| 2020 | -8,834.36% | 29.74% |
| 2019 | -6,809.29% | 154.66% |
| 2018 | -2,673.84% | 41.48% |
| 2017 | -1,889.93% | -76.82% |
| 2016 | -8,154.35% | -28.79% |
| 2015 | -11,451.13% | 29.28% |
| 2014 | -8,857.87% | -18.11% |
| 2013 | -10,816.67% | 32.76% |
| 2012 | -8,147.42% | -8.24% |
| 2011 | -8,878.88% | -26.85% |
| 2010 | -12,138.52% | 1.58% |
| 2009 | -11,949.55% | 147.18% |
| 2008 | -4,834.34% | 165.41% |
| 2007 | -1,821.44% | -9.09% |
| 2006 | -2,003.64% | 125.12% |
| 2005 | -890.03% | 0.45% |
| 2004 | -886.00% | -19.73% |
| 2003 | -1,103.81% | -43.14% |
| 2002 | -1,941.35% | -13.98% |
| 2001 | -2,256.92% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | -36.36% | -99.74% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | -8,391.15% | -39.59% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.